LIDCX | VIHAX | LIDCX / VIHAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 16 years | 9 years | - |
Gain YTD | 8.192 | 5.296 | 155% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1500 | 3000 | 50% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 394M | 8.4B | 5% |
Annual Yield % from dividends | 2.25 | 4.87 | 46% |
Returns for 1 year | 10.84 | 8.15 | 133% |
Returns for 3 years | 9.78 | 9.76 | 100% |
Returns for 5 years | 16.77 | 14.60 | 115% |
Returns for 10 years | 15.36 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHSCX | 51.00 | N/A | N/A |
BlackRock Health Sciences Opps Inv C | |||
FCGIX | 19.95 | -0.07 | -0.35% |
NYLI PineStone Global Equity Class I | |||
BRIFX | 16.97 | -0.08 | -0.47% |
Baron Real Estate Income Retail | |||
BCSKX | 8.35 | -0.05 | -0.60% |
BlackRock Commodity Strategies K | |||
FADAX | 23.91 | -0.26 | -1.08% |
Fidelity Advisor Dividend Growth A |